Hemab Therapeutics Holdings, Inc. (COAG) News
Follow Hemab Therapeutics Holdings, Inc. (COAG) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Keli Walbert elected to Hemab board, joins Audit Committee
Hemab appointed Keli Walbert to its Board as a Class I director and named her to the Audit Committee, effective immediately.Original SEC Filing: Hemab Therapeutics Holdings, Inc. [ COAG ] - 8-K - Sep. 24, 2026This is an
REGULATION | Sep 24, 2026, 08:15 PM UTC
L
Hemab Therapeutics doses first participant in Phase 1 HMB-003 trial
Hemab Therapeutics said the first participant has been dosed in its Phase 1 clinical trial of HMB-003 for heavy menstrual bleeding management.
EARNINGS | Sep 17, 2026, 12:01 PM UTC
H
Hemab Therapeutics presents sutacimig data at ISTH Congress
Hemab Therapeutics...
GEOPOLITICS | Jul 14, 2026, 11:51 AM UTC
L
COAG - Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
COAG - Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
EQUITY | Jun 26, 2026, 01:00 PM UTC